1003 related articles for article (PubMed ID: 9862736)
21. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice.
Nicoletti F; Di Marco R; Zaccone P; Xiang M; Magro G; Grasso S; Morrone S; Santoni A; Shoenfeld Y; Garotta G; Meroni P
Eur J Immunol; 2000 Feb; 30(2):438-47. PubMed ID: 10671199
[TBL] [Abstract][Full Text] [Related]
22. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
[TBL] [Abstract][Full Text] [Related]
23. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
Merino R; Shibata T; De Kossodo S; Izui S
Eur J Immunol; 1989 Nov; 19(11):2131-7. PubMed ID: 2599002
[TBL] [Abstract][Full Text] [Related]
24. Ocular inflammation in MRL/Mp-lpr/lpr mice.
Jabs DA; Prendergast RA
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1944-7. PubMed ID: 2032814
[TBL] [Abstract][Full Text] [Related]
25. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice.
Cruse JM; Lewis RE; Dilioglou S
Exp Mol Pathol; 2000 Dec; 69(3):211-22. PubMed ID: 11115362
[TBL] [Abstract][Full Text] [Related]
26. Genetic heterogeneity in rheumatoid arthritis mouse models induced by extrinsic and intrinsic factors.
Mizuki S; Oishi H; Zhang MC; Kamogawa J; Miyazaki T; Ono M; Takahashi S; Yamamoto H; Nose M
Pathol Int; 2010 Jun; 60(6):430-7. PubMed ID: 20518897
[TBL] [Abstract][Full Text] [Related]
27. Genetic basis of autoimmune sialadenitis in MRL/lpr lupus-prone mice: additive and hierarchical properties of polygenic inheritance.
Nishihara M; Terada M; Kamogawa J; Ohashi Y; Mori S; Nakatsuru S; Nakamura Y; Nose M
Arthritis Rheum; 1999 Dec; 42(12):2616-23. PubMed ID: 10616009
[TBL] [Abstract][Full Text] [Related]
28. Arteritis in a novel congenic strain of mice derived from MRL/Lpr lupus mice: genetic dissociation from glomerulonephritis and limited autoantibody production.
Nose M; Nishimura M; Ito MR; Toh J; Shibata T; Sugisaki T
Am J Pathol; 1996 Nov; 149(5):1763-9. PubMed ID: 8909264
[TBL] [Abstract][Full Text] [Related]
29. Genetic basis of murine lupus.
Santiago-Raber ML; Laporte C; Reininger L; Izui S
Autoimmun Rev; 2004 Jan; 3(1):33-9. PubMed ID: 14871647
[TBL] [Abstract][Full Text] [Related]
30. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus.
Treadwell EL; Cohen P; Williams D; O'Brien K; Volkman A; Eisenberg R
J Immunol; 1993 Jan; 150(2):695-9. PubMed ID: 8419494
[TBL] [Abstract][Full Text] [Related]
31. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
32. Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice.
Vidal S; Kono DH; Theofilopoulos AN
J Clin Invest; 1998 Feb; 101(3):696-702. PubMed ID: 9449705
[TBL] [Abstract][Full Text] [Related]
33. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
Chan OT; Madaio MP; Shlomchik MJ
J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951
[TBL] [Abstract][Full Text] [Related]
34. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
35. Characterization of reciprocal Lmb1-4 interval MRL-Faslpr and C57BL/6-Faslpr congenic mice reveals significant effects from Lmb3.
Santiago-Raber ML; Haraldsson MK; Theofilopoulos AN; Kono DH
J Immunol; 2007 Jun; 178(12):8195-202. PubMed ID: 17548658
[TBL] [Abstract][Full Text] [Related]
36. Induction of various autoantibodies by mutant gene lpr in several strains of mice.
Izui S; Kelley VE; Masuda K; Yoshida H; Roths JB; Murphy ED
J Immunol; 1984 Jul; 133(1):227-33. PubMed ID: 6609979
[TBL] [Abstract][Full Text] [Related]
37. beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice.
Christianson GJ; Blankenburg RL; Duffy TM; Panka D; Roths JB; Marshak-Rothstein A; Roopenian DC
J Immunol; 1996 Jun; 156(12):4932-9. PubMed ID: 8648144
[TBL] [Abstract][Full Text] [Related]
38. Decreased cochlear DNA receptor staining in MRL.MpJ-Fas(lpr) autoimmune mice with hearing loss.
Kaylie DM; Hefeneider SH; Kempton JB; Siess DC; Vedder CT; Merkens LS; Trune DR
Laryngoscope; 2001 Jul; 111(7):1275-80. PubMed ID: 11568554
[TBL] [Abstract][Full Text] [Related]
39. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
[TBL] [Abstract][Full Text] [Related]
40. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice.
Apelgren LD; Bailey DL; Fouts RL; Short L; Bryan N; Evans GF; Sandusky GE; Zuckerman SH; Glasebrook A; Bumol TF
Cell Immunol; 1996 Oct; 173(1):55-63. PubMed ID: 8871601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
